NCT05298982

Brief Summary

This study is a prospective cohort study to evaluate the long-term effects of early activity and mobilisation compared to standard care on disability, function and health status for patients at 1, 2 and 5 years after recruitment of patients randomised into the TEAM Phase III RCT (ClinicalTrials.gov NCT03133377). The primary outcome of the study will be the level of disability as measured by the World Health Organisation's Disability Schedule 2.0, 12 level (WHODAS) at 2 years after recruitment.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
250

participants targeted

Target at P75+ for all trials

Timeline
6mo left

Started Feb 2020

Longer than P75 for all trials

Geographic Reach
1 country

16 active sites

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress93%
Feb 2020Nov 2026

Study Start

First participant enrolled

February 11, 2020

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

March 18, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 28, 2022

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2023

Completed
3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2026

Expected
Last Updated

March 28, 2022

Status Verified

March 1, 2022

Enrollment Period

3.7 years

First QC Date

March 18, 2022

Last Update Submit

March 18, 2022

Conditions

Keywords

Early activity and mobilizationrehabilitationintensive carehealth status

Outcome Measures

Primary Outcomes (1)

  • Level of disability measured with the World Health Organisation's Disability Assessment Schedule (WHODAS) 2.0

    level of disability as measured by the World Health Organisation's Disability Schedule 2.0, 2 level (WHODAS) at 2 years after recruitment.

    Assessed 2 years after recruitment

Secondary Outcomes (21)

  • Time from randomisation until death

    From date of randomisation until date of death from all cause, censored at 5 years

  • All-cause mortality

    From date of randomisation to 1 year

  • All-cause mortality

    From date of randomisation to 2 years

  • All-cause mortality

    From date of randomisation to 5 years

  • Generic function and disability measured using World Health Organisation's Disability Assessment Schedule (WHODAS)

    Assessed 1 year after recruitment

  • +16 more secondary outcomes

Study Arms (2)

Intervention arm: TEAM protocol

Based on TEAM (III) protocol patients will be assessed daily by an ICU physiotherapist using the ICU Mobility Scale (IMS) to determine the dosage and type of active exercises the patient will receive, using the early activity and mobilisation protocol. This protocol is hierarchical, with the objective of each intervention session beginning with the highest level of activity possible for the longest time possible, which then steps down to lower levels of activity if the patient fatigues. The intervention will be administered on all days in which the patient is admitted to ICU during the index hospitalisation, censored at 28days after.

Behavioral: Early activity and Mobilisation Intervention

Standard of Care arm: TEAM protocol

Based on TEAM (III) protocol the control group will receive standard care from physiotherapy staff not involved in delivering the intervention. We have previously established that standard care in Australia for a patient receiving prolonged IMV (control group intervention) frequently involves no active exercise out of bed.

Interventions

The early activity and mobilisation intervention is comprised of exercises based on a reproducible, physiological approach using both strength and functional activities

Intervention arm: TEAM protocol

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Up to 380 critically ill adult Australian patients, who met all of the inclusion criteria and none of the exclusion criteria, as defined in the TEAM Phase III RCT and consent to follow-up.

You may qualify if:

  • Enrolled in the TEAM Phase III RCT Protocol.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (16)

Royal Prince Alfred Hospital

Camperdown, New South Wales, 2050, Australia

Location

John Hunter Hospital

Sydney, New South Wales, Australia

Location

Royal North Shore Hospital

Sydney, New South Wales, Australia

Location

Wollongong Hospital

Wollongong, New South Wales, Australia

Location

Sunshine Coast University Hospital

Birtinya, Queensland, Australia

Location

Mater Health

Brisbane, Queensland, Australia

Location

Mater Private Hospital

Brisbane, Queensland, Australia

Location

Caboolture Hospital

Caboolture, Queensland, Australia

Location

Redcliffe Hospital

Redcliffe, Queensland, 4020, Australia

Location

Toowoomba Hospital

Toowoomba, Queensland, Australia

Location

Launceston General Hospital

Launceston, Tasmania, Australia

Location

Geelong Hospital - Barwon Health

Geelong, Victoria, 3220, Australia

Location

Cabrini Hospital

Malvern, Victoria, 3144, Australia

Location

Royal Melbourne Hospital

Parkville, Victoria, 3050, Australia

Location

Alfred Hospital

Prahran, Victoria, 3004, Australia

Location

Sunshine Hospital

St Albans, Victoria, 3021, Australia

Location

Related Publications (6)

  • Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA. 2014 Apr 2;311(13):1308-16. doi: 10.1001/jama.2014.2637.

    PMID: 24638143BACKGROUND
  • Herridge MS, Tansey CM, Matte A, Tomlinson G, Diaz-Granados N, Cooper A, Guest CB, Mazer CD, Mehta S, Stewart TE, Kudlow P, Cook D, Slutsky AS, Cheung AM; Canadian Critical Care Trials Group. Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med. 2011 Apr 7;364(14):1293-304. doi: 10.1056/NEJMoa1011802.

    PMID: 21470008BACKGROUND
  • TEAM Study Investigators; Hodgson C, Bellomo R, Berney S, Bailey M, Buhr H, Denehy L, Harrold M, Higgins A, Presneill J, Saxena M, Skinner E, Young P, Webb S. Early mobilization and recovery in mechanically ventilated patients in the ICU: a bi-national, multi-centre, prospective cohort study. Crit Care. 2015 Feb 26;19(1):81. doi: 10.1186/s13054-015-0765-4.

    PMID: 25715872BACKGROUND
  • Iwashyna TJ. Survivorship will be the defining challenge of critical care in the 21st century. Ann Intern Med. 2010 Aug 3;153(3):204-5. doi: 10.7326/0003-4819-153-3-201008030-00013. No abstract available.

    PMID: 20679565BACKGROUND
  • Iwashyna TJ, Netzer G. The burdens of survivorship: an approach to thinking about long-term outcomes after critical illness. Semin Respir Crit Care Med. 2012 Aug;33(4):327-38. doi: 10.1055/s-0032-1321982. Epub 2012 Aug 8.

    PMID: 22875378BACKGROUND
  • Higgins AM, Pettila V, Harris AH, Bailey M, Lipman J, Seppelt IM, Webb SA. The critical care costs of the influenza A/H1N1 2009 pandemic in Australia and New Zealand. Anaesth Intensive Care. 2011 May;39(3):384-91. doi: 10.1177/0310057X1103900308.

    PMID: 21675057BACKGROUND

Related Links

MeSH Terms

Conditions

Critical IllnessMotor Activity

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsBehavior

Study Officials

  • Prof Carol Hodgson

    ANZIC-RC

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 18, 2022

First Posted

March 28, 2022

Study Start

February 11, 2020

Primary Completion

November 1, 2023

Study Completion (Estimated)

November 1, 2026

Last Updated

March 28, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

Locations